Developing the science base for reducing tobacco harm.
暂无分享,去创建一个
E. Borgida | D. Hatsukami | S. Hecht | A. Joseph | S. Murphy | M. Lesage | M. Kotlyar | P. Pentel | C. Le | Joni Jensen | S. Hecht
[1] A. Malarcher,et al. Cigarette Smoking Among Adults in the United States , 2008 .
[2] D. Hatsukami,et al. Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[3] S. Siegel,et al. Translating basic science to improve pharmacotherapy for nicotine dependence. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[4] D. Hatsukami,et al. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[5] S. Feng,et al. Short‐Term Clinical Exposure Evaluation of a Second‐Generation Electrically Heated Cigarette Smoking System , 2007, Journal of clinical pharmacology.
[6] D. Hatsukami,et al. Smokeless tobacco brand switching: a means to reduce toxicant exposure? , 2007, Drug and alcohol dependence.
[7] G. Scherer,et al. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. , 2007, Regulatory toxicology and pharmacology : RTP.
[8] M. Thun,et al. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco , 2007, Tobacco Control.
[9] D. Hatsukami,et al. Effects of high dose transdermal nicotine replacement in cigarette smokers , 2007, Pharmacology Biochemistry and Behavior.
[10] N. Benowitz,et al. Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. , 2007, Analytical chemistry.
[11] D. Hatsukami,et al. Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. , 2007, Chemical research in toxicology.
[12] M. Utell,et al. Changes in markers of epithelial permeability and inflammation in chronic smokers switching to a nonburning tobacco device (Eclipse). , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[13] A. Breland,et al. Clinical laboratory evaluation of potential reduced exposure products for smokers. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[14] D. Vallone,et al. Findings and implications from a national study on potential reduced exposure products (PREPs). , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[15] L. Weinehall,et al. Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? , 2006, Scandinavian journal of public health.
[16] Matthew J Carpenter,et al. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[17] D. Hatsukami,et al. Toxicant Exposure in Cigarette Reducers versus Light Smokers , 2006, Cancer Epidemiology Biomarkers & Prevention.
[18] A. Tverdal,et al. Health consequences of reduced daily cigarette consumption , 2006, Tobacco Control.
[19] D. Hatsukami,et al. Comparison of Polymorphisms in Genes Involved in Polycyclic Aromatic Hydrocarbon Metabolism with Urinary Phenanthrene Metabolite Ratios in Smokers , 2006, Cancer Epidemiology Biomarkers & Prevention.
[20] K. Lohr,et al. Tobacco use: prevention, cessation, and control. , 2006, Evidence report/technology assessment.
[21] J. Foulds,et al. Role of snus in initiation and cessation of tobacco smoking in Sweden , 2006, Tobacco Control.
[22] D. Hatsukami,et al. Biomarkers to assess the utility of potential reduced exposure tobacco products. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[23] Stephen S Hecht,et al. Tobacco-specific nitrosamines in new tobacco products. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[24] R. Kinser,et al. Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[25] S. Murphy,et al. Inactivation of CYP2A6 and CYP2A13 during Nicotine Metabolism , 2006, Journal of Pharmacology and Experimental Therapeutics.
[26] Josue P. Keely,et al. Ever users versus never users of a "less risky" cigarette. , 2005, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.
[27] Deirdre Lawrence,et al. Methods to assess potential reduced exposure products. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[28] P. Sullivan,et al. Is Swedish snus associated with smoking initiation or smoking cessation? , 2005, Tobacco Control.
[29] R. Jain,et al. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[30] A. Tverdal,et al. Health consequences of smoking 1–4 cigarettes per day , 2005, Tobacco Control.
[31] D. Hatsukami,et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. , 2005, Chest.
[32] Merete Osler,et al. Effect of smoking reduction on lung cancer risk. , 2005, JAMA.
[33] J. Hughes,et al. The feasibility of smoking reduction: an update. , 2005, Addiction.
[34] J E Henningfield,et al. Toward a comprehensive long term nicotine policy , 2005, Tobacco Control.
[35] E. Weiderpass,et al. Smokeless tobacco use and risk of cancer of the pancreas and other organs , 2005, International journal of cancer.
[36] D. Hatsukami,et al. Hope or hazard? What research tells us about "potentially reduced-exposure" tobacco products , 2005 .
[37] A. Joseph,et al. Predictors of smoking reduction without formal intervention. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[38] R. Tyndale,et al. Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.
[39] D. Hatsukami,et al. Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes , 2005, Cancer Epidemiology Biomarkers & Prevention.
[40] Neal L. Benowitz,et al. Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.
[41] Å. Westin,et al. Effects of smoking cessation and reduction in asthmatics. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[42] R. Kinser,et al. Short‐Term Exposure Evaluation of Adult Smokers Switching From Conventional to First‐Generation Electrically Heated Cigarettes During Controlled Smoking , 2005, Journal of clinical pharmacology.
[43] E. Gilpin,et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[44] Richard Doll,et al. Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.
[45] D. Hatsukami,et al. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. , 2004, Journal of the National Cancer Institute.
[46] J. Hughes,et al. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. , 2004, Journal of consulting and clinical psychology.
[47] R. Krueger,et al. Community tobacco control leaders’ perceptions of harm reduction , 2004, Tobacco Control.
[48] P. Lantz,et al. Tobacco harm reduction: what do the experts think? , 2004, Tobacco Control.
[49] S. Hecht,et al. Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni , 2004, Tobacco Control.
[50] D. Hatsukami,et al. Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[51] D. Hatsukami,et al. Characteristics of cigarette smokers seeking treatment for cessation versus reduction. , 2004, Addictive behaviors.
[52] K. Haustein,et al. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). , 2004, International journal of clinical pharmacology and therapeutics.
[53] M. Thun,et al. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8 , 2004, BMJ : British Medical Journal.
[54] A. Nissinen,et al. Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study , 2004, European Journal of Epidemiology.
[55] M. Fiore,et al. Transdisciplinary science applied to the evaluation of treatments for tobacco use. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[56] D. Jerina,et al. r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[57] K. Fagerström,et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden , 2003, Tobacco control.
[58] Michael J Thun,et al. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. , 2003, Cancer research.
[59] A. Breland,et al. Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance™ , 2003, Tobacco control.
[60] M. Lesage,et al. Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations , 2003, Psychopharmacology.
[61] D. Burns. Epidemiology of smoking-induced cardiovascular disease. , 2003, Progress in cardiovascular diseases.
[62] Mary Ellen Wewers,et al. Distribution of daily smokers by stage of change: Current Population Survey results. , 2003, Preventive medicine.
[63] J. Vestbo,et al. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976–1998: a pooled cohort study , 2003, Journal of epidemiology and community health.
[64] K. Warner,et al. Hardening and the hard-core smoker: concepts, evidence, and implications. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[65] K. Fagerström,et al. Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[66] A. Breland,et al. Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[67] J. Vestbo,et al. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. , 2002, American journal of epidemiology.
[68] B. Bombick,et al. Relationship between FTC 'tar' and urine mutagenicity in smokers of tobacco-burning or Eclipse cigarettes. , 2002, Mutation research.
[69] James R. Anderson,et al. Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[70] Å. Westin,et al. Influence of long-term smoking reduction on health risk markers and quality of life. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[71] J. Vestbo,et al. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study , 2002, Thorax.
[72] S. Hecht,et al. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.
[73] M. Lesage,et al. Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine , 2002, Pharmacology Biochemistry and Behavior.
[74] S. Hecht,et al. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. , 2002, Chemical research in toxicology.
[75] R. Tyndale,et al. Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking Behavior , 2002, Therapeutic drug monitoring.
[76] S. Shiffman,et al. Smokers' beliefs about “Light” and “Ultra Light” cigarettes , 2001, Tobacco control.
[77] Å. Westin,et al. Effect of smoking reduction and cessation on cardiovascular risk factors. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[78] T. Eissenberg,et al. Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[79] R. Wallace,et al. Clearing the smoke: assessing the science base for tobacco harm reduction. , 2001 .
[80] J. Gitchell,et al. cigarettes Smokers ' beliefs about ' ' Light ' ' and ' ' Ultra Light ' ' , 2001 .
[81] K. Fagerström,et al. Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit , 2000, Tobacco control.
[82] N. Benowitz,et al. Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism , 2000, Clinical pharmacology and therapeutics.
[83] T. Eissenberg,et al. Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. , 2000, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[84] E. Perez-stable,et al. Ethnic differences in N-glucuronidation of nicotine and cotinine. , 1999, The Journal of pharmacology and experimental therapeutics.
[85] N. Benowitz,et al. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. , 1998, The Journal of pharmacology and experimental therapeutics.
[86] R. MacCoun. Toward a psychology of harm reduction. , 1998, The American psychologist.
[87] M. Eriksson,et al. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case‐control study , 1998, International journal of cancer.
[88] H. Johansson,et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck , 1998, Cancer.
[89] K. Fagerström,et al. Nicotine replacement: a new approach to reducing tobacco-related harm. , 1998, The European respiratory journal.
[90] J E Henningfield,et al. Tobacco dependence treatments: review and prospectus. , 1998, Annual review of public health.
[91] T V Perneger,et al. Distributions of smokers by stage: international comparison and association with smoking prevalence. , 1997, Preventive medicine.
[92] D. Hatsukami,et al. Society for Research on Nicotine and Tobacco. , 1997, Addiction.
[93] B. Bombick,et al. Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. , 1996, Mutation research.
[94] J. Henningfield. Introduction to tobacco harm reduction as a complementary strategy to smoking cessation , 1995, Tobacco Control.
[95] J. Hughes. Applying harm reduction to smoking , 1995, Tobacco Control.
[96] M. Thun,et al. Excess mortality among cigarette smokers: changes in a 20-year interval. , 1995, American journal of public health.
[97] G. Giovino,et al. Smokeless tobacco brand preference and brand switching among US adolescents and young adults , 1995 .
[98] J. Manson,et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. , 1994, Archives of internal medicine.
[99] N. Benowitz,et al. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. , 1994, The New England journal of medicine.
[100] N. Benowitz,et al. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers , 1993, Clinical pharmacology and therapeutics.
[101] A. Auquier,et al. Changes in patterns of cigarette smoking and lung cancer risk: results of a case-control study. , 1989, British Journal of Cancer.
[102] F. Berrino,et al. Modifying risk of developing lung cancer by changing habits of cigarette smoking. , 1984, British medical journal.
[103] E. Wynder,et al. Impact of long-term filter cigarette usage on lung and larynx cancer risk: a case-control study. , 1979, Journal of the National Cancer Institute.
[104] R. Doll,et al. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.